Clicky

Pharming Grp Nv Leid(PHGUF)

Description: Pharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming’s technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company’s commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.


Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Molecular Biology Genetic Engineering Recombinant Proteins Genetic Disorder Recombinant Biological Engineering Recombinant Dna Bleeding Innovative Therapies Pharming

Home Page: www.pharming.com

Darwinweg 24
Leiden, 2333 CR
Netherlands
Phone: 31 71 524 7400


Officers

Name Title
Dr. Sijmen de Vries M.B.A., M.D. President, CEO & Executive Director
Mr. Jeroen Wakkerman Chief Financial Officer
Ms. Mireille Sanders M.Sc. Chief Operations Officer
Ms. Susanne Embleton Investor Relations Manager
Mr. Ruud Van Outersterp Chief Ethics & Compliance Officer
Ms. Ines Bernal Chief People Officer
Dr. Anurag Relan M.D., MPH Chief Medical Officer
Mr. Stephen Toor Chief Commercial Officer & GM Americas
Dr. Alexander Breidenbach M.B.A. Chief Business Officer
Dr. Bruno M. L. Giannetti Consultant

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 178.5714
Trailing PE: 0
Price-to-Book MRQ: 2.2931
Price-to-Sales TTM: 2.084
IPO Date:
Fiscal Year End: December
Full Time Employees: 382
Back to stocks